These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26041938)

  • 1. VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells.
    Ye X; Fan F; Bhattacharya R; Bellister S; Boulbes DR; Wang R; Xia L; Ivan C; Zheng X; Calin GA; Wang J; Lu X; Ellis LM
    Mol Cancer Res; 2015 Sep; 13(9):1274-82. PubMed ID: 26041938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudogene fms-related tyrosine kinase 1 pseudogene 1 (FLT1P1) cooperates with RNA binding protein dyskeratosis congenita 1 (DKC1) to restrain trophoblast cell proliferation and angiogenesis by targeting fms-related tyrosine kinase 1 (FLT1) in preeclampsia.
    Chi Z; Sun Y; Yu Z; Zhou F; Wang H; Zhang M
    Bioengineered; 2021 Dec; 12(1):8885-8897. PubMed ID: 34699328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
    Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
    PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global DNA and protein interactomes of FLT1P1 (Fms-related tyrosine kinase 1 pseudogene 1) revealed its molecular regulatory functions associated with preeclampsia.
    Zhao L; Xin S; Wu Y; Huang S; Xu K; Xu Y; Ruan D; Wu B; Chen D; He X
    Mol Biol Rep; 2023 Feb; 50(2):1267-1279. PubMed ID: 36451001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
    Zhang Y; Wang X; Xu B; Wang B; Wang Z; Liang Y; Zhou J; Hu J; Jiang B
    Oncol Rep; 2013 Oct; 30(4):1976-84. PubMed ID: 23900443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
    Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
    Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
    Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
    Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
    Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
    Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
    Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of vascular endothelial growth factor receptor 1-positive hematopoietic progenitor cell clusters in human colorectal carcinoma metastasis].
    Yang ZH; Yang M; Xiong HZ; Li XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):696-9. PubMed ID: 18504182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived vascular endothelial growth factor (VEGF)-a facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway.
    Liu W; Xu J; Wang M; Wang Q; Bi Y; Han M
    Int J Oncol; 2011 Nov; 39(5):1213-20. PubMed ID: 21785819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine VEGF/VEGFR1 signaling in a subpopulation of cells associates with aggressive osteosarcoma.
    Ohba T; Cates JM; Cole HA; Slosky DA; Haro H; Ando T; Schwartz HS; Schoenecker JG
    Mol Cancer Res; 2014 Aug; 12(8):1100-11. PubMed ID: 24759089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant, ectopic expression of VEGF and VEGF receptors 1 and 2 in malignant colonic epithelial cells. Implications for these cells growth via an autocrine mechanism.
    Ahluwalia A; Jones MK; Szabo S; Tarnawski AS
    Biochem Biophys Res Commun; 2013 Aug; 437(4):515-20. PubMed ID: 23831629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interaction.
    Huang SM; Chen TS; Chiu CM; Chang LK; Liao KF; Tan HM; Yeh WL; Chang GR; Wang MY; Lu DY
    Endocr Relat Cancer; 2014 Feb; 21(1):73-84. PubMed ID: 24165321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
    Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
    Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor receptors during male germ cell differentiation in the mouse.
    Nalbandian A; Dettin L; Dym M; Ravindranath N
    Biol Reprod; 2003 Sep; 69(3):985-94. PubMed ID: 12773425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated pseudogene CTNNAP1 promote tumor growth in human cancer by downregulating its cognate gene CTNNA1 expression.
    Chen X; Zhu H; Wu X; Xie X; Huang G; Xu X; Li S; Xing C
    Oncotarget; 2016 Aug; 7(34):55518-55528. PubMed ID: 27487124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.